drugset
drugset / Trial / NCT04036617

Study of NaQuinate in Healthy Volunteers

NCT04036617 ↗

Phase 1 Unknown 58 enrolled Haoma Medica Limited Parexel · collab
RandomizedParallel-groupQuadruple-blindOther

Summary

Phase 1, randomised, double-blind, placebo-controlled study of NaQuinate in healthy subjects after single ascending oral (PO) doses and multiple ascending PO doses.

Timeline

Start
2019-06-18
Primary completion
2019-12-31
Completion
2020-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject NaQuinate Unknown 10 mg Oral
Subject NaQuinate Unknown 70 mg Oral
Subject NaQuinate Unknown 150 mg Oral

Indications

osteoporosis